St. Jude Plans Trial To Study Renal Denervation Outcomes
This article was originally published in The Pink Sheet Daily
Landmark trial will evaluate whether reductions in blood pressure caused by renal denervation translate to clinical improvements in patients with hard-to-treat hypertension.
You may also be interested in...
Research In Brief
St Jude launches post-market study of its renal denervation system. More research news
Boston Scientific Enters Renal Denervation Market Via Vessix Acquisition
Deal gives Boston Scientific access to the V2 radiofrequency energy-based renal denervation catheter system for drug-resistant hypertension.
New Products In Brief
Recent approvals and launches include St. Jude Medical’s EnligHTN renal denervation system for hypertension and Zeltiq Aesthetics’ expanded CoolSculpting clearance for fat reduction.